Shree Nath Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 04-07-2024
- Paid Up Capital ₹ 0.83 M
as on 04-07-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 49.50 M
as on 04-07-2024
- Satisfied Charges ₹ 17.31 M
as on 04-07-2024
- Revenue 69.22%
(FY 2023)
- Profit 17.89%
(FY 2023)
- Ebitda 49.11%
(FY 2023)
- Net Worth 18.99%
(FY 2023)
- Total Assets 21.41%
(FY 2023)
About Shree Nath Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.83 M.
The company currently has active open charges totaling ₹4.95 Cr. The company has closed loans amounting to ₹1.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shubham Gupta and Ravinder Gupta serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PTC130543
- Company No.
130543
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Nov 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shree Nath Life Sciences Private Limited offer?
Shree Nath Life Sciences Private Limited offers a wide range of products and services, including Herbal Powder, Calcium Sennoside, Plant Extracts, Boswellia Serrata Extract, Resin Oil, Frankincense Oil, Ashwagandha Extract.
Who are the key members and board of directors at Shree Nath Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shubham Gupta  | Director | 21-Nov-2017 | Current |
| Ravinder Gupta | Director | 11-Nov-2004 | Current |
Financial Performance and Corporate Structure Insights of Shree Nath Life Sciences.
Shree Nath Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 69.22% increase. The company also saw a substantial improvement in profitability, with a 17.89% increase in profit. The company's net worth Soared by an impressive increase of 18.99%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Nath Life Sciences?
In 2023, Shree Nath Life Sciences had a promoter holding of 33.86% and a public holding of 66.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
4 years 1 month Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 21 Dec 2016 | ₹4.95 Cr | Open |
Bank Of India Creation Date: 03 Dec 2010 | ₹1.73 Cr | Satisfied |
How Many Employees Work at Shree Nath Life Sciences?
Shree Nath Life Sciences has a workforce of 72 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
As of May 14, 2015, Shree Nath Life Sciences has raised a total of ₹ 2.2 Cr, with the most recent deal valued at ₹ 7.2 M. Access detailed insights into the company’s deals, including security allotments, mergers, acquisitions, and strategic partnerships that have shaped its growth.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
